Clinical Trials Browser

Phase 1 × Neoplasms × LY3300054 × Clear all

NCT03495323 2021-04-15

A Study of Prexasertib (LY2606368), CHK1 Inhibitor, and LY3300054, PD-L1 Inhibitor, in Patients With Advanced Solid Tumors

Phase 1 Completed

Neoplasms